fluorouracil has been researched along with doxoform in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hegg, R; Heinzmann, D; Ismael, G; Jackisch, C; Kim, SB; Lichinitser, M; Lum, B; Melichar, B; Muehlbauer, S; Pienkowski, T; Semiglazov, V | 1 |
1 trial(s) available for fluorouracil and doxoform
Article | Year |
---|---|
Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Infusions, Subcutaneous; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Receptor, ErbB-2; Trastuzumab; Young Adult | 2012 |